Back to Search
THEODORE DEWEESE, M.D.
M.D.
Radiation Oncology Physician
NPI: 1528003373Individual
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
D47485(MD)D14152(MD)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
OTHER
Class of 1990
Research & Publications (20)
Inadequate "caretaker" gene function and human cancer development.
PMID 12710692·Methods Mol Biol·2003
6-review
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.
PMID 11606381·Cancer Res·2001
3-trial
Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate.
PMID 10688072·Urology·2000
6-review
Evaluation of safety in a radiation oncology setting using failure mode and effects analysis.
PMID 19409731·Int J Radiat Oncol Biol Phys·2009
8-other
Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites.
PMID 19470598·Mol Cancer Res·2009
7-preclinical
Evaluating advanced technologies in radiation oncology: when and how should randomized trials be done?
PMID 19476271·Oncology (Williston Park)·2009
8-other
DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.
PMID 18974140·Cancer Res·2008
8-other
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.
PMID 18560003·JAMA·2008
8-other
Radiotherapy augments the immune response to prostate cancer in a time-dependent manner.
PMID 18561247·Prostate·2008
7-preclinical
High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities.
PMID 18640502·Int J Radiat Oncol Biol Phys·2008
7-preclinical
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
PMID 18672274·Urology·2008
4-observational
Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.
PMID 17656219·Urology·2007
8-other
Radiation therapy for prostate cancer: the role for dose escalation.
PMID 18025613·Compr Ther·2007
8-other
Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy.
PMID 17382158·Urology·2007
3-trial
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy.
PMID 17418972·Int J Radiat Oncol Biol Phys·2007
4-observational
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.
PMID 17473206·Clin Cancer Res·2007
7-preclinical
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
PMID 17513807·J Clin Oncol·2007
8-other
Defining the appropriate measure of success for adjuvant radiation following prostatectomy.
PMID 17549086·Nat Clin Pract Urol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 N WOLFE ST
BALTIMORE, MD 21287 - Phone
- (410) 955-8964
Quick Facts
- NPI
- 1528003373
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile